Navigation Links
Medivation Announces Third Quarter 2010 Financial Results Teleconference and Webcast on November 5, 2010
Date:10/29/2010

SAN FRANCISCO, Oct. 29 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that it will host a teleconference and webcast with management to discuss third quarter 2010 financial results and provide a general business update on November 5, 2010, at 4:30 p.m. Eastern Time. A press release for the third quarter ended September 30, 2010 will be released after markets close on November 5, 2010.

Interested parties may call 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals interested in listening to the live call via webcast may do so by visiting http://www.medivation.com. A replay of the webcast will be available on the Company's website for 30 days.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. Together with its corporate partners Pfizer and Astellas, Medivation currently has investigational drugs in Phase 3 development to treat advanced prostate cancer, mild-to-moderate Alzheimer's disease and Huntington disease. For more information, please visit us at www.medivation.com.


'/>"/>
SOURCE Medivation, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Medivation Announces Second Quarter 2010 Financial Results Teleconference and Webcast on August 9, 2010
2. Medivation Announces Organizational Changes to Support Anticipated Growth and Future Commercialization
3. Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update
4. Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer
5. Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer
6. Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients
7. Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimers Disease
8. Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
9. Medivation Presents Positive New Data on Dimebons Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimers Disease
10. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
11. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... SANTA CLARA, Calif. , Jan. 23, 2017 ... hand protection market, Frost & Sullivan recognizes Ansell, ... 2016 Global Frost & Sullivan Company of the ... strong customer-centric approach, and a wide global footprint ... eminence in the hand protection market. The Company,s ...
(Date:1/23/2017)... Jan. 23, 2017 MouthWatch LLC announced today that ... ranked as the best intraoral camera on DentalCompare,s list of ... spot overall. The #1 product was the CollaPlug Absorbable ... intraoral camera was "…incredibly popular because it is by far ... a small sticker price, it doesn,t sacrifice quality imaging." ...
(Date:1/23/2017)... Jan. 23, 2017 Direct-to-consumer ... devices sold and 65% increase in consumable sales, quarter-over-quarter ... Corp. (NASDAQ: DRIO ), a leader in ... of the Dario™ Blood Glucose Monitoring System, an all-in-one ... mobile app-based and minimally invasive smart diabetes management solution. ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 24, 2017 , ... “The Octagon of Spiritual Balances”: ... Spiritual Balances” is the creation of published author, Pastor Bernard J. Weathers, pastor of ... a bachelor degree in religious education and a master degree in theology. , ““The ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... on Friday, January 20, with the bipartisan original co-sponsorship of nearly one-quarter of ... January 12. The National Association of Chain Drug Stores (NACDS) strongly backs the ...
(Date:1/24/2017)... ... 23, 2017 , ... Texas Home Health, an AccentCare, Inc. ... care service companies: Padre Home Health in Corpus Christi, Texas, and Royalty Personal ... regarded in their respective markets, these two agencies align with Texas Home Health’s ...
(Date:1/24/2017)... , ... January 24, 2017 , ... The National Council ... for drug and alcohol awareness, have worked with communities to designate the last full ... January 23-29, 2017, the theme is “Shatter the Myths.” As a community, we ...
(Date:1/23/2017)... ... January 23, 2017 , ... Ultimate Medical Academy ... Summit to be held March 23-25, 2017 in Tampa, and reminded educators and ... The keynote speakers include Dr. Michelle R. Weise, executive director of the Sandbox ...
Breaking Medicine News(10 mins):